The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...

The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.

Nasacort takes up to a week to achieve full benefits for allergy symptoms, and should be used daily for optimal allergy ...

Los Angeles Rhinoplasty Pros announced today the launch of a comprehensive online educational resource designed to inform prospective rhinoplasty patients throughout the Los Angeles and Beverly Hills ...